Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2010
09/15/2010CN101069742B Pancreatic kininogenase tablet and preparing method
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14
09/14/2010US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides
09/14/2010US7795287 Therapeutic substituted hydantoins and related compounds
09/14/2010US7795222 administering peptide comprising claimed amino acid sequence; insulin-like growth factor; therapy for vision defects, skin disorders; wound healing agents; antiulcer agents
09/14/2010CA2479353C N-substituted benzothiophenesulfonamide derivative
09/14/2010CA2441501C Rho-kinase inhibitors
09/10/2010WO2010102196A2 Controlled-release ophthalmic vehicles
09/10/2010WO2010102192A2 Non-steroidal anti-inflammatory ophthalmic compositions
09/10/2010WO2010102052A2 Methods of inhibiting photoreceptor apoptosis
09/10/2010WO2010102031A2 Methods for treating ocular inflammatory diseases
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors
09/10/2010WO2010100218A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010WO2010100217A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754157A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010CA2754156A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010CA2754065A1 Methods of inhibiting photoreceptor apoptosis
09/10/2010CA2753947A1 Non-steroidal anti-inflammatory ophthalmic compositions
09/10/2010CA2753847A1 Methods for treating ocular inflammatory diseases
09/10/2010CA2753236A1 Pyrrolopyrimidines used as kinase inhibitors
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227928 Non-steroidal anti-inflammatory ophthalmic compositions
09/09/2010US20100227905 Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
09/09/2010US20100227904 Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
09/09/2010US20100227888 Modulators of cftr
09/09/2010US20100227879 Liquid formulations for treatment of diseases or conditions
09/09/2010US20100227868 Treatment methods with brimonidine
09/09/2010US20100227841 Patient populations and treatment methods
09/09/2010US20100227823 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
09/09/2010US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
09/09/2010US20100226997 Controlled-release ophthalmic vehicles
09/09/2010US20100226992 Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
09/09/2010US20100226971 Ultrasound-enhanced intrascleral delivery of macromolecules
09/09/2010US20100226963 Bi-functional co-polymer use for opthalmic and other topical and local applications
09/09/2010US20100226962 Peri-corneal drug delivery device
09/09/2010US20100226957 Protein-Based Artificial Retinas
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226916 Compositions and methods for treating ocular diseases and conditions
09/09/2010US20100226878 Methods of inhibiting photoreceptor apoptosis
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226085A1 Anti-angiogenic compositions and methods of use
09/08/2010EP2224949A1 Use of urokinase type plasminogen activator inhibitors for the treatment of corneal disorders
09/08/2010EP1901755B1 New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers
09/08/2010EP1638524B1 Composition and method for the treatment of water related ear disorders
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101822756A Medicament composition for treating tinnitus and preparation method thereof
09/08/2010CN101822748A Method for preparing medlar and rehmannia root wine
09/08/2010CN101822712A Pellet for oral administration and external use and preparation process thereof
09/08/2010CN101822700A Medicinal composition with function of alleviating visual fatigue and preparation method thereof
09/08/2010CN101822693A Medicine treating tympanitis
09/08/2010CN101822677A Eye drops for cataracts
09/08/2010CN101264131B Chinese medicine extracting liquid eye plaster and preparation thereof
09/08/2010CN101204451B Peroral Chinese traditional medicine prescription for glaucoma
09/08/2010CN101181433B Chinese medicine medicament for curing pterygium
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790771 Chloramine-t as a wound healing agent and viricide, particularly the herpes and varicella viruses; pruritus; skin disorders; diseasesof the mucous membranes, organs and tissues; with the exception of treatment of retro-viral (HIV) diseases; dermatitis; acne; psoriasis; side effect reduction
09/07/2010US7790764 Biologically active macrolides, compositions, and uses thereof
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790700 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
09/07/2010US7790669 Parkinson's disease, Alzheimer's disease or Huntington's disease or a neurological injury that results from ischemia such as a stroke; tissue repair
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010US7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/02/2010WO2010099436A1 Methods of treating retinitis pigmentosa
09/02/2010WO2010099368A1 Ocular implants comprising kinase inhibitors
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097201A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
09/02/2010WO2010057028A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
09/02/2010WO2010030757A3 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
09/02/2010US20100222369 Treatment for dry eye conditions
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222365 Substituted triazole deriviatives as oxytocin antagonists
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222308 Ophthalmic, otic or nasal pharmaceutical composition and the use thereof
09/02/2010US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
09/02/2010US20100222280 PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/02/2010US20100221344 Functionalized Nanoceria Composition For Ophthalmic Treatment
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010CA2753652A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
09/02/2010CA2752891A1 Peptidomimetic cyclic compounds for treating retinitis pigmentosa
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751296A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2222714A2 Polysaccharide gel compositions and methods for sustained delivery of drugs
09/01/2010EP2222648A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
09/01/2010EP2222316A2 Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 531